In no-injury feces detection, FBN1 methylation risk size was up to 30.87; this higher risk had illustrated that FBN1 methylation is a no-injury fecal biomarker in clinically early CRC diagnosis and screening. The gene discussed is FBN1; the disease is colorectal carcinoma.